 | Soleno Therapeutics, Inc. (NASDAQ:SLNO) Expected to Announce Earnings of -$0.04 Per Share
americanbankingnews.com - April 18 at 6:18 PM |
| Soleno Therapeutics, Inc. (NASDAQ:SLNO) Sees Significant Increase in Short Interest
americanbankingnews.com - April 18 at 4:44 AM |
 | Soleno Therapeutics Participates in Prader-Willi Syndrome (PWS) DCCR Town Hall
finance.yahoo.com - April 15 at 12:21 AM |
| Soleno Therapeutics (NASDAQ:SLNO) Stock Price Passes Below Fifty Day Moving Average of $1.90
americanbankingnews.com - April 9 at 3:42 AM |
| Financial Comparison: Helius Medical Technologies (NASDAQ:HSDT) vs. Soleno Therapeutics (NASDAQ:SLNO)
americanbankingnews.com - March 31 at 8:44 AM |
| Soleno Therapeutics (SLNO) Enters Oversold Territory
finance.yahoo.com - March 30 at 9:01 AM |
| Here's Why We're Watching Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation
finance.yahoo.com - March 29 at 5:55 PM |
| Soleno Therapeutics, Inc. (NASDAQ:SLNO) Short Interest Up 125.5% in March
americanbankingnews.com - March 29 at 10:55 AM |
| SLNO Jul 2021 4.000 call
au.finance.yahoo.com - March 13 at 9:23 AM |
| Soleno to Participate in the 31st Annual Oppenheimer Healthcare Conference
finance.yahoo.com - March 9 at 5:38 PM |
|
| Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Contact the Firm
finance.yahoo.com - March 9 at 12:38 PM |
 | Soleno Therapeutics (SLNO) Is in Oversold Territory: What's Next?
msn.com - March 9 at 7:38 AM |
| Why Soleno Therapeutics Is Trading Lower Today
msn.com - March 8 at 12:51 PM |
| Soleno Shares Are Trading Lower After FDA Demands Additional Study For DCCR Program In Prader-Willi Syndrome
finance.yahoo.com - March 8 at 12:51 PM |
| Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
finance.yahoo.com - March 3 at 6:39 PM |
| Soleno Therapeutics, Vanderbilt University In Research Pact For K(ATP) Channel Activators
finance.yahoo.com - February 23 at 1:05 PM |
| Soleno Therapeutics Provides Recap of Key Opinion Leader Webinar on DCCR for Treatment of Prader-Willi Syndrome
finance.yahoo.com - February 5 at 10:07 AM |
| SLNO Feb 2021 4.000 call
au.finance.yahoo.com - February 2 at 6:25 PM |
| SLNO Feb 2021 3.000 call
au.finance.yahoo.com - January 28 at 6:08 PM |
| Soleno Therapeutics to Host Key Opinion Leader Meeting on DCCR for the Treatment of Prader-Willi Syndrome
finance.yahoo.com - January 28 at 1:07 PM |
| SLNO Feb 2021 1.000 call
au.finance.yahoo.com - January 27 at 10:56 PM |
 | Soleno Therapeutics: Could Be Big Fish In The Small Pond
seekingalpha.com - January 10 at 12:03 PM |
| Soleno Therapeutics, Inc. (SLNO)
finance.yahoo.com - January 5 at 11:09 PM |
| Soleno Therapeutics to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
finance.yahoo.com - January 4 at 9:36 AM |
| Is SLNO A Good Stock To Buy Now?
finance.yahoo.com - December 14 at 9:09 AM |
| Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome
finance.yahoo.com - December 11 at 10:10 AM |
| Soleno Therapeutics EPS misses by $0.02
seekingalpha.com - November 10 at 7:03 PM |
| Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 10 at 7:02 PM |
| Soleno Therapeutics presents body composition results from mid-stage DCCR study in prader-willi syndrome
seekingalpha.com - November 4 at 7:58 AM |
| Soleno Therapeutics Announces Presentation of Body Composition Results from DESTINY PWS, a Phase III Trial of DCCR in Prader-Willi Syndrome
finance.yahoo.com - November 3 at 7:53 PM |
|
| Soleno Therapeutics Announces Late-Breaking Oral Presentation with Body Composition Results from Phase III DESTINY PWS Trial of DCCR in Prader-Willi Syndrome at ObesityWeek® 2020 Meeting
finance.yahoo.com - October 29 at 1:02 PM |
 | Soleno Therapeutics' Shares March Higher, Can It Continue?
nasdaq.com - October 2 at 12:48 PM |
| Updated data from Soleno's DCCR late-stage study shows positive outcome in obesity disorder
seekingalpha.com - September 30 at 5:32 PM |
| Soleno Therapeutics to Participate in Fireside Chat at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
finance.yahoo.com - September 15 at 12:36 PM |
| Soleno (SLNO) in Focus: Stock Moves 6.3% Higher
finance.yahoo.com - August 20 at 1:54 PM |
| A Second Look At Soleno Therapeutics
seekingalpha.com - August 17 at 8:13 PM |
| SLNO Oct 2020 1.000 call
ca.finance.yahoo.com - August 17 at 8:27 AM |
| SLNO Jan 2021 5.000 call
ca.finance.yahoo.com - August 17 at 8:27 AM |
| Soleno Therapeutics EPS beats by $0.04
seekingalpha.com - August 10 at 5:11 PM |
| Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 10 at 5:11 PM |
| Soleno (SLNO) to report Q2 Earnings: What's in the Cards?
www.nasdaq.com - July 27 at 1:21 PM |
| Soleno (SLNO) to report Q2 Earnings: What's in the Cards?
finance.yahoo.com - July 27 at 1:21 PM |
 | Soleno Therapeutics (SLNO) Stock
markets.businessinsider.com - July 27 at 12:17 AM |
| ORGS, SLNO, CDTX, BLPH, ARCT added to Indexes
seekingalpha.com - June 29 at 9:48 AM |
| Soleno Therapeutics Added to Russell 3000® Index
finance.yahoo.com - June 29 at 9:48 AM |
| Trade Alert: Jack Schuler At Soleno Therapeutics, Inc. (NASDAQ:SLNO), Has Just Spent US$8.5m Buying 83% More Shares
finance.yahoo.com - June 29 at 9:48 AM |
| Have Insiders Been Buying Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares?
finance.yahoo.com - June 29 at 9:48 AM |
| Soleno Therapeutics Announces Closing of $57.5 Million Public Offering of Common Stock, Including the Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - June 26 at 6:37 PM |
| Translate Bio (TBIO) in Focus: Stock Moves 11.7% Higher
finance.yahoo.com - June 26 at 12:28 AM |
| Hedge Funds Have Never Been This Bullish On Soleno Therapeutics, Inc. (SLNO)
finance.yahoo.com - June 25 at 7:28 PM |
